Table 4. Correspondence of 19q12 amplification status determined by in situ hybridisation (ISH) and OncoScan assay.
| 19q12 amplicon OncoScan assay | ||||||
|---|---|---|---|---|---|---|
| Case | EC subtype | 19q12 ISH amplification | CCNE1 | URI1 | POP4 | PLEKHF1 |
| 026 | serous | high | High CN gain | High CN gain | High CN gain | High CN gain |
| 033 | clear cell | high | High CN gain | High CN gain | High CN gain | High CN gain |
| 042 | hg endometrioid | high | High CN gain | High CN gain | High CN gain | High CN gain |
| 040 | serous | high | High CN gain | High CN gain | High CN gain | High CN gain |
| 034 | hg endometrioid | high | High CN gain | High CN gain | High CN gain | High CN gain |
| 027 | hg endometrioid | low | High CN gain | High CN gain | High CN gain | High CN gain |
| 046 | serous | low | CN gain | CN gain | CN gain | CN gain |
| 029 | carcinosarcoma | low | CN gain | CN gain | CN gain | CN gain |
| 045 | serous | low | CN gain | CN gain | CN gain | CN gain |
| 028 | hg endometrioid | low | - | - | - | - |
| 031 | lg endometrioid | low | - | - | - | - |
| 035 | lg endometrioid | low | - | - | - | - |
| 036 | lg endometrioid | low | - | - | - | - |
| 037 | serous | low | - | - | - | - |
| 038 | hg endometrioid | low | - | - | - | - |
| 039 | lg endometrioid | low | - | - | - | - |
| 041 | lg endometrioid | low | - | - | - | - |
| 030 | lg endometrioid | no | - | - | - | - |
| 047 | lg endometrioid | no | - | - | - | - |
| 048 | lg endometrioid | no | - | - | - | - |
| 043 | lg endometrioid | no | - | - | - | - |
lg: low grade; hg: high grade